SCHEMBL1444162

SCHEMBL1444162

CCOC(=O)C(Cl)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
LMNA P02545 2/20 0.42
HSD17B10 Q99714 1/20 0.42
ALOX15 P16050 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
SOAT1 P35610 1/20 0.40
PIN1 Q13526 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
KMT2A Q03164 1/20 0.37
TRPA1 O75762 1/20 0.37
MMP8 P22894 1/20 0.35
CYP2D6 P10635 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1444159 0.87 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL28534575 0.83 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL1763670 0.81 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL9939069 0.80 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL54869 0.80 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL1763671 0.79 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL7940226 0.78 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL28000135 0.78 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL10820963 0.78 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL27923771 0.78 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10ALOX15MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122055351-A Process for the production of 2-methoxy malonate 巴斯夫欧洲公司 2026-05-15 CN disclosed
US-20250360143-A1 COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY UNIV CONNECTICUT (US) 2025-11-27 US disclosed
EP-4536215-A2 COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY University of Connecticut (US) 2025-04-16 EP disclosed
WO-2023239767-A2 COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY UNIVERSITY OF CONNECTICUT (US) 2023-12-14 WO disclosed
CN-113045447-A 2-amino malonamide and synthetic method thereof 南京红杉生物科技有限公司 2021-06-29 CN disclosed
US-20180265467-A1 PYRAZOLIDINE DERIVATIVES AND RELATED COMPOUNDS SELVITA S.A. (PL) 2018-09-20 US disclosed
EP-3356331-A1 PYRAZOLIDINE DERIVATIVES AND RELATED COMPOUNDS Selvita S.A. (PL) 2018-08-08 EP disclosed
US-20120252791-A1 Heterocyclic GTP Cyclohydrolase 1 Inhibitors For the Treatment of Pain CHILDREN'S MEDICAL CENTER CORPORATION 2012-10-04 US disclosed
CN-1894198-B Process for producing dialkyl alpha-fluoromalonates BAYER CROPSCIENCE AG 2012-07-18 CN disclosed
US-8080549-B2 Endothelin receptor antagonists CONCERT PHARMACEUTICALS, INC. (US) 2011-12-20 US disclosed
US-8071596-B2 Endothelin receptor antagonists CONCERT PHARMACEUTICALS, INC. (US) 2011-12-06 US disclosed
WO-2011035009-A1 HETEROCYCLIC GTP CYCLOHYDROLASE 1 INHIBITORS FOR THE TREATMENT OF PAIN HERCULES TECHNOLOGY MANAGEMENT CO V, INC. (US) 2011-03-24 WO disclosed
US-20100063076-A1 Endothelin receptor antagonists SUN PHARMACEUTICAL INDUSTRIES, INC. 2010-03-11 US disclosed
US-20090005394-A1 Endothelin receptor antagonists SUN PHARMACEUTICAL INDUSTRIES, INC. 2009-01-01 US disclosed
WO-2008088727-A2 ENDOTHELIN RECEPTOR ANTAGONISTS CONCERT PHARMACEUTICALS, INC. (US) 2008-07-24 WO disclosed
EP-0045081-B1 TRISUBSTITUTED IMIDAZOLE DERIVATIVES, PROCESSES FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE CIBA-GEIGY AG (CH) 1986-01-08 EP disclosed
WO-1983002613-A1 TRISUBSTITUTED OXAZO COMPOUNDS SALLMANN, ALFRED 1983-08-04 WO disclosed
EP-0045081-A2 Trisubstituted imidazole derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use CIBA-GEIGY AG (CH) 1982-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250360143-A1 COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY PLAT, SERPINE1, SERPINC1 ALDH1A1 902/4885LMNA 766/4885HSD17B10 931/4885
US-20180265467-A1 PYRAZOLIDINE DERIVATIVES AND RELATED COMPOUNDS LDHB, LDHA, PDK1 ALDH1A1 55/4885LMNA 240/4885HSD17B10 247/4885
US-20100063076-A1 Endothelin receptor antagonists EDNRA, EDNRB, ECE1 ALDH1A1 3474/4885LMNA 1734/4885HSD17B10 2449/4885
US-20120252791-A1 Heterocyclic GTP Cyclohydrolase 1 Inhibitors For the Treatment of Pain GGH, GGPS1, GGT1 ALDH1A1 910/4885LMNA 4833/4885HSD17B10 666/4885
US-20090005394-A1 Endothelin receptor antagonists EDNRA, EDNRB, ECE1 ALDH1A1 3953/4885LMNA 974/4885HSD17B10 2391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.